Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Sophie Van Welden

20 Results

2022

Magnetic resonance texture analysis is superior to magnetization transfer imaging for longitudinal assessment of fibrosis in experimental colitis

Simon BosIsabelle De KockSophie Van WeldenPieter HindryckxMartine De VosGeert VilleirsDebby Laukens

Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study

Cara De GalanGerard GonzalesSophie Van WeldenSimon TavernierTriana Lobatón OrtegaMartine De VosDebby LaukensPieter Hindryckx

A1 Journal Article in CLINICAL AND TRANSLATIONAL MEDICINE

The quorum sensing peptide EntF* promotes colorectal cancer metastasis in mice : a new factor in the host-microbiome interaction

Evelien WynendaeleNathan DebunneYorick JanssensAnton De SpiegeleerFrederick VerbekeLiesa TackSophie Van WeldenEvy GoossensChristophe Van De WieleDebby LaukensPeter Van EenooLars VereeckeFilip Van ImmerseelOlivier De WeverBart De Spiegeleer

A1 Journal Article in BMC BIOLOGY

2021

Can serum metabolomics discriminate the Crohn’s disease fibrostenotic phenotype?

Simon BosSophie Van WeldenMartine De VosPieter HindryckxTriana Lobatón OrtegaLynn VanhaeckeDebby Laukens

Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study

Cara De GalanSophie Van WeldenSimon TavernierTriana Lobatón OrtegaMartine De VosDebby LaukensPieter Hindryckx

Long-term environmental hypoxia does not impact experimental Crohn's like ileitis

Cara De GalanSophie Van WeldenTriana Lobatón OrtegaPieter HindryckxMartine De VosDebby Laukens

Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis

Cara De GalanMartine De VosPieter HindryckxDebby LaukensSophie Van Welden

A1 Journal Article in BIOLOGY-BASEL

2020

Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaGerard GonzalesMartine De VosDebby LaukensPieter Hindryckx

2019

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaGerard GonzalesMartine De VosDebby LaukensPieter Hindryckx

2017

Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

Sophie Van WeldenMartine De VosBen WielockxSimon TavernierMelissa DullaersSara NeytBenedicte DescampsLindsey DevisscherSarah DevrieseLien Van den BosscheTom HolvoetAnn BaeyensChristian VanhoveFilip De VosBruno VerhasseltBart LambrechtSophie JanssensDirk ElewautDebby LaukensPieter Hindryckx

A1 Journal Article in JOURNAL OF PATHOLOGY

Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD

Sophie Van WeldenPieter Hindryckx

A1 Journal Article in NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY

Prolyl hydroxylase domain-containing protein 1 as potential therapeutic target for inflammatory bowel disease

Sophie Van WeldenDebby LaukensPieter Hindryckx

T84 monolayers are superior to Caco-2 as a model system of colonocytes

Sarah DevrieseLien Van den BosscheSophie Van WeldenTom HolvoetPieter HindryckxMartine De VosDebby Laukens

A1 Journal Article in HISTOCHEMISTRY AND CELL BIOLOGY

Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn’s disease-like ileitis

Lien Van den BosscheSarah DevrieseSophie Van WeldenTom HolvoetLindsey DevisscherPieter HindryckxMartine De VosDebby Laukens

A1 Journal Article in LABORATORY INVESTIGATION

Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local Rho kinase inhibitor

Tom HolvoetSarah DevrieseYves-Paul VandewynckelLindsey DevisscherLien Van den BosscheSophie Van WeldenMelissa DullaersRoosmarijn VandenbrouckeRiet De RyckeKarel GeboesPieter HindryckxMartine De VosDebby Laukens

A1 Journal Article in GASTROENTEROLOGY

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimantal colitis in mice

Pieter HindryckxLindsey DevisscherSarah DevrieseSophie Van WeldenTom HolvoetRamiro Vilchez VargasLynn VanhaeckeTom Van de WieleMartine De VosDebby Laukens

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice

Lien Van den BosschePieter HindryckxLindsey DevisscherSarah DevrieseSophie Van WeldenTom HolvoetRamiro Vilchez VargasLynn VanhaeckeTom Van de WieleMartine De VosDebby Laukens

A1 Journal Article in APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice

Pieter HindryckxLindsey DevisscherSarah DevrieseSophie Van WeldenRamiro Vilchez VargasLynn VanhaeckeTom Van de WieleMartine De VosDebby Laukens

2014

Ly49E Expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseases

Aline Van AckerJessica FiltjensSophie Van WeldenSylvie TaveirneEls Van AmmelMandy VanheesLindsey DevisscherTessa KerreTom TaghonBart VandekerckhoveJean PlumGeorges Leclercq

A1 Journal Article in PLOS ONE

2013

Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn's disease/infectious colitis and healthy controls

Sophie Van WeldenDebby LaukensLiesbeth FerdinandeMartine De VosPieter Hindryckx

A1 Journal Article in JOURNAL OF INFLAMMATION-LONDON